Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 45% ± 22% | |
eye | 10 studies | 31% ± 9% | |
lung | 9 studies | 24% ± 7% | |
peripheral blood | 9 studies | 27% ± 11% | |
heart | 5 studies | 19% ± 4% | |
kidney | 5 studies | 19% ± 4% | |
liver | 5 studies | 28% ± 10% | |
intestine | 4 studies | 24% ± 7% | |
adipose | 4 studies | 23% ± 5% | |
uterus | 3 studies | 32% ± 10% | |
breast | 3 studies | 20% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6107.59 | 1445 / 1445 | 100% | 12.46 | 183 / 183 |
prostate | 100% | 6996.58 | 245 / 245 | 100% | 8.74 | 502 / 502 |
thymus | 100% | 7883.24 | 653 / 653 | 99% | 10.18 | 601 / 605 |
breast | 100% | 7530.53 | 459 / 459 | 99% | 9.39 | 1105 / 1118 |
brain | 100% | 6905.96 | 2637 / 2642 | 99% | 13.41 | 695 / 705 |
pancreas | 100% | 4370.06 | 328 / 328 | 98% | 7.51 | 174 / 178 |
stomach | 100% | 4801.33 | 359 / 359 | 97% | 9.20 | 278 / 286 |
lung | 100% | 7404.47 | 578 / 578 | 97% | 8.24 | 1121 / 1155 |
bladder | 100% | 7738.05 | 21 / 21 | 97% | 5.69 | 487 / 504 |
ovary | 100% | 10522.03 | 180 / 180 | 96% | 7.67 | 414 / 430 |
intestine | 100% | 7174.38 | 966 / 966 | 96% | 7.04 | 505 / 527 |
skin | 100% | 7204.33 | 1808 / 1809 | 96% | 6.71 | 452 / 472 |
kidney | 100% | 4138.62 | 89 / 89 | 95% | 7.83 | 856 / 901 |
uterus | 100% | 9215.72 | 170 / 170 | 95% | 5.98 | 435 / 459 |
adrenal gland | 100% | 4764.00 | 258 / 258 | 93% | 7.88 | 213 / 230 |
liver | 98% | 2260.09 | 222 / 226 | 58% | 2.38 | 234 / 406 |
adipose | 100% | 6486.13 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 9485.15 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 9.06 | 29 / 29 |
spleen | 100% | 6621.10 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.42 | 1 / 1 |
muscle | 99% | 3206.52 | 794 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 3106.76 | 834 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 5.39 | 43 / 45 |
eye | 0% | 0 | 0 / 0 | 93% | 5.47 | 74 / 80 |
peripheral blood | 65% | 3448.86 | 601 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071560 | Biological process | cellular response to transforming growth factor beta stimulus |
GO_0035640 | Biological process | exploration behavior |
GO_0051899 | Biological process | membrane depolarization |
GO_0035864 | Biological process | response to potassium ion |
GO_0009791 | Biological process | post-embryonic development |
GO_0032259 | Biological process | methylation |
GO_0048147 | Biological process | negative regulation of fibroblast proliferation |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0008542 | Biological process | visual learning |
GO_0048873 | Biological process | homeostasis of number of cells within a tissue |
GO_0065003 | Biological process | protein-containing complex assembly |
GO_0045064 | Biological process | T-helper 2 cell differentiation |
GO_0048536 | Biological process | spleen development |
GO_0060216 | Biological process | definitive hemopoiesis |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0036211 | Biological process | protein modification process |
GO_0048144 | Biological process | fibroblast proliferation |
GO_0090310 | Biological process | negative regulation of DNA methylation-dependent heterochromatin formation |
GO_0009952 | Biological process | anterior/posterior pattern specification |
GO_0006915 | Biological process | apoptotic process |
GO_0035162 | Biological process | embryonic hemopoiesis |
GO_0048172 | Biological process | regulation of short-term neuronal synaptic plasticity |
GO_0045815 | Biological process | transcription initiation-coupled chromatin remodeling |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0035097 | Cellular component | histone methyltransferase complex |
GO_0071339 | Cellular component | MLL1 complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0042800 | Molecular function | histone H3K4 methyltransferase activity |
GO_0003682 | Molecular function | chromatin binding |
GO_0070577 | Molecular function | lysine-acetylated histone binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0106363 | Molecular function | protein-cysteine methyltransferase activity |
GO_0003680 | Molecular function | minor groove of adenine-thymine-rich DNA binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0140999 | Molecular function | histone H3K4 trimethyltransferase activity |
GO_0140945 | Molecular function | histone H3K4 monomethyltransferase activity |
GO_0045322 | Molecular function | unmethylated CpG binding |
GO_0005515 | Molecular function | protein binding |
Gene name | KMT2A |
Protein name | Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.364) (ALL-1) (CXXC-type zinc finger protein 7) (Cysteine methyltransferase KMT2A) (EC 2.1.1.-) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] KMT2A KMT2A/MAML2 fusion protein KMT2A-MLLT6 fusion protein Lysine methyltransferase 2A (Myeloid/lymphoid or mixed-lineage leukemia (Trithorax homolog, Drosophila), isoform CRA_b) Histone-lysine N-methyltransferase (EC 2.1.1.364) NUTM2A-KMT2A fusion protein Lysine methyltransferase 2A |
Synonyms | MLL1 hCG_39304 EPS15 MAML2 HTRX CXXC7 TRX1 MLLT6 fusion HRX ALL1 MLL |
Description | FUNCTION: Histone methyltransferase that plays an essential role in early development and hematopoiesis . Catalytic subunit of the MLL1/MLL complex, a multiprotein complex that mediates both methylation of 'Lys-4' of histone H3 (H3K4me) complex and acetylation of 'Lys-16' of histone H4 (H4K16ac) . Catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) via a non-processive mechanism. Part of chromatin remodeling machinery predominantly forms H3K4me1 and H3K4me2 methylation marks at active chromatin sites where transcription and DNA repair take place . Has weak methyltransferase activity by itself, and requires other component of the MLL1/MLL complex to obtain full methyltransferase activity . Has no activity toward histone H3 phosphorylated on 'Thr-3', less activity toward H3 dimethylated on 'Arg-8' or 'Lys-9', while it has higher activity toward H3 acetylated on 'Lys-9' . Binds to unmethylated CpG elements in the promoter of target genes and helps maintain them in the nonmethylated state . Required for transcriptional activation of HOXA9 . Promotes PPP1R15A-induced apoptosis . Plays a critical role in the control of circadian gene expression and is essential for the transcriptional activation mediated by the CLOCK-BMAL1 heterodimer (By similarity). Establishes a permissive chromatin state for circadian transcription by mediating a rhythmic methylation of 'Lys-4' of histone H3 (H3K4me) and this histone modification directs the circadian acetylation at H3K9 and H3K14 allowing the recruitment of CLOCK-BMAL1 to chromatin (By similarity). Also has auto-methylation activity on Cys-3882 in absence of histone H3 substrate . . |
Accessions | A0A3B3ITT7 ENST00000686588.1 H0YEU4 A0A8I5KVV7 ENST00000527869.7 ENST00000649699.1 [Q03164-2] ENST00000531904.7 A0A4D6WLI1 ENST00000649878.2 A0A8I5KQ03 A0A8I5QJJ1 ENST00000649690.2 A0A3B3ISN4 A0A8I5KXR3 ENST00000691002.1 H7C5W4 ENST00000649666.2 ENST00000689424.1 ENST00000533790.3 ENST00000529852.3 ENST00000420751.4 ENST00000389506.10 [Q03164-1] ENST00000685719.1 A0A8I5KTQ4 ENST00000686370.1 ENST00000691053.1 E9PR05 A0A3B3ITT0 A0A8I5KVD4 A0AA34QVI8 ENST00000685397.1 A0A8I5KY70 H7C5V8 A0A4D6WIU0 A0A8I5KRW5 ENST00000532204.6 ENST00000534358.8 [Q03164-3] A0A7G9ZE50 ENST00000688355.1 Q03164 A0A8F7GQG2 A0A8I5KRT6 A0A4D6WQ80 ENST00000693536.1 ENST00000685498.1 A0A8I5KQV5 A0A8I5KW84 ENST00000710560.1 A0A3S6YZ73 |